Muse Bio is making stem cell access safer, simpler, and more inclusive—by transforming menstrual blood into a powerful, renewable source of mesenchymal stem cells (MSCs).
Today, autologous stem cell collection often requires painful and expensive procedures like bone marrow or fat tissue extraction. We’re changing that.
With Muse Bio’s non-invasive, at-home collection platform, we turn menstrual blood into clinically valuable MSCs—enabling accessible stem cell banking, supporting regenerative medicine research, and powering next-generation cell therapy development.
Our approach lowers financial and physical barriers to stem cell preservation while unlocking underused biological potential. We’re building the first renewable stem cell supply chain rooted in equity, science, and trust.
🩸We are ready to accept samples in the San Francisco Bay Area, and if you're interested in participating please click the link on our website.🩸
Join us in pioneering a new era of regenerative health, rooted in the power of your own biology.
🌐 Learn more at www.mycells.bio
📬 Contact: muse@mycells.bio
Company Details
- Employees
- 5
- Address
- San Francisco, Ca 94114, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- HQ
- San Francisco, CA
Muse.bio Questions
Muse.Bio's LinkedIn profile is https://www.linkedin.com/company/musebio-cells
Muse.Bio has
5 employees.
View email and phone details for 5
employees at Muse.Bio.
Muse.Bio's industry is
Biotechnology Research
Muse.Bio's top competitors are
Orca Bio,
Trybe Health,
Monomer Bio,
Highyield Neurology,
Cue Health,
Cryste (Novapro Co. Ltd),
Foresite Labs,
Ge Healthcare,
Valley Research Park,
Science Laboratories Of Practical Education.
Muse.Bio's categories are Biotechnology Research
